SARAH BROWN: Open Payments
NPI 1619570744 · NANCY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$917 in 55 payments from 18 companies in 2025. Trend: 2023 $263 · 2024 $607 · 2025 $917
Food & beverage: $917
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 12 | $174 |
| Otsuka America Pharmaceutical, Inc. | 15 | $146 |
| Boston Scientific Corporation | 1 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $60 |
| Novo Nordisk Inc | 3 | $54 |
| Almatica Pharma LLC | 2 | $45 |
| Lilly USA, LLC | 2 | $36 |
| PFIZER INC. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $32 |
Products named: FANAPT, REXULTI, WaveWriter Alpha Prime 16, TRINTELLIX, LOREEV XR, MOUNJARO, NURTEC ODT, Auvelity.
Industry payments across KY — which companies pay providers there.
